Matches in Wikidata for { <http://www.wikidata.org/entity/Q99608070> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q99608070 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99608070 description "scientific article published on 22 September 2020" @default.
- Q99608070 description "wetenschappelijk artikel" @default.
- Q99608070 description "наукова стаття, опублікована 22 вересня 2020" @default.
- Q99608070 name "A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis" @default.
- Q99608070 name "A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis" @default.
- Q99608070 type Item @default.
- Q99608070 label "A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis" @default.
- Q99608070 label "A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis" @default.
- Q99608070 prefLabel "A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis" @default.
- Q99608070 prefLabel "A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis" @default.
- Q99608070 P1433 Q99608070-202F0440-3C41-4DBF-AFB3-DF1247ABBF5E @default.
- Q99608070 P1476 Q99608070-ED8315D6-F3D5-4AE5-8B97-F33F6999BBE6 @default.
- Q99608070 P2093 Q99608070-0B7696F6-3282-434F-B07A-5C5AB9F285BD @default.
- Q99608070 P2093 Q99608070-39B96F61-B79D-4A51-91B7-894DC50E1083 @default.
- Q99608070 P2093 Q99608070-497986D9-D461-45C9-8CEB-EBFD7FFC3B13 @default.
- Q99608070 P2093 Q99608070-5A958AA6-2D6F-4687-8A4B-746E8AF71E81 @default.
- Q99608070 P2093 Q99608070-6394865F-F419-451C-AF94-96537800EB47 @default.
- Q99608070 P2093 Q99608070-663DFB75-B0D2-40E5-8934-4F31D38E0FD6 @default.
- Q99608070 P2093 Q99608070-E6CECE8E-D3F9-49EC-B299-D86F7D4F9CEC @default.
- Q99608070 P275 Q99608070-91955ba5-9719-4b9e-b2a9-14dc0e7438dc @default.
- Q99608070 P31 Q99608070-5A47C8CA-9C12-4B91-90D1-2D9D8B5CA6CB @default.
- Q99608070 P356 Q99608070-4D7F237C-DCB2-4BB2-8A05-614084E5441B @default.
- Q99608070 P50 Q99608070-4167FA6B-7BAF-4912-B435-8E06878F73E5 @default.
- Q99608070 P50 Q99608070-5C360B63-9995-45A9-A3CB-F7E2FE07C5BD @default.
- Q99608070 P50 Q99608070-6D960FEA-FDEC-4B32-835D-0690EAD54AAD @default.
- Q99608070 P577 Q99608070-46A2F8E3-B0E7-4FE6-8B1E-200166657089 @default.
- Q99608070 P6216 Q99608070-52b14a7d-9716-47bf-addb-eca596fe52b4 @default.
- Q99608070 P698 Q99608070-771DDEF2-510B-46C4-BBB5-5D07077D3681 @default.
- Q99608070 P356 ANNRHEUMDIS-2020-218447 @default.
- Q99608070 P698 32963047 @default.
- Q99608070 P1433 Q4767876 @default.
- Q99608070 P1476 "A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis" @default.
- Q99608070 P2093 "Amel Lahmar" @default.
- Q99608070 P2093 "Christina Soubrane" @default.
- Q99608070 P2093 "Corinne Esperet" @default.
- Q99608070 P2093 "Frederic Marrache" @default.
- Q99608070 P2093 "Investigators" @default.
- Q99608070 P2093 "Peter Wung" @default.
- Q99608070 P2093 "Raphael Bejuit" @default.
- Q99608070 P275 Q34179348 @default.
- Q99608070 P31 Q13442814 @default.
- Q99608070 P356 "10.1136/ANNRHEUMDIS-2020-218447" @default.
- Q99608070 P50 Q56954418 @default.
- Q99608070 P50 Q88877972 @default.
- Q99608070 P50 Q89643360 @default.
- Q99608070 P577 "2020-09-22T00:00:00Z" @default.
- Q99608070 P6216 Q50423863 @default.
- Q99608070 P698 "32963047" @default.